Seyedmehdi Shojaee, Ph.D.
Affiliations: | 2013 | Genetic, Molecular, and Cell Biology | University of Southern California, Los Angeles, CA, United States |
Area:
OncologyGoogle:
"Seyedmehdi Shojaee"Parents
Sign in to add mentor| Markus Muschen | grad student | 2013 | USC | |
| (Induction of hypersignaling as a therapeutic approach for treatment of BCR-ABL1 positive Acute Lymphoblastic Leukemia (ALL) cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chan LN, Murakami MA, Robinson ME, et al. (2020) Signalling input from divergent pathways subverts B cell transformation. Nature |
| Chan LN, Murakami MA, Caesar R, et al. (2019) Signaling Input from Divergent Pathways Subverts Malignant B-Cell Transformation Blood. 134: 3944-3944 |
| Chan LN, Chen Z, Braas D, et al. (2018) Author Correction: Metabolic gatekeeper function of B-lymphoid transcription factors. Nature |
| Chan LN, Shojaee S, Hurtz C, et al. (2018) Divergent Evolutionary Trajectories of Erk- and Stat5-Activating Lesions in Acute Lymphoblastic Leukemia Blood. 132: 568-568 |
| Aravanis AA, Oxnard GR, Maddala T, et al. (2018) Abstract LB-343: Development of plasma cell-free DNA (cfDNA) assays for early cancer detection: first insights from the Circulating Cell-Free Genome Atlas Study (CCGA) Cancer Research. 78 |
| Chan LN, Chen Z, Braas D, et al. (2017) Metabolic gatekeeper function of B-lymphoid transcription factors. Nature. 1-5 |
| Shojaee S, Chan LN, Buchner M, et al. (2016) PTEN opposes negative selection and enables oncogenic transformation of pre-B cells. Nature Medicine |
| Chen Z, Shojaee S, Buchner M, et al. (2016) Corrigendum: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature |
| Cao Q, Gearhart MD, Gery S, et al. (2016) BCOR regulates myeloid cell proliferation and differentiation. Leukemia |
| Chan LN, Hurtz C, Xiao G, et al. (2016) BCL6 Is Critical to Overcome Oncogene-Induced Senescence in RAS-Mediated B Cell Transformation Blood. 128: 438-438 |